What is Givosiran: Uses, Dosage, Side Effects and More

Givosiran is a specialized medication designed to prevent painful attacks in people with acute hepatic porphyria, a rare genetic condition. This injectable medicine works by targeting the root cause of porphyria attacks, helping reduce how often they occur and how severe they become.

If you or someone you care about has been diagnosed with acute hepatic porphyria, you're likely looking for answers about treatment options. Givosiran represents a significant breakthrough in managing this challenging condition, offering hope for a more stable and comfortable life.

What is Givosiran?

Givosiran is a prescription medication specifically developed for adults with acute hepatic porphyria. It belongs to a class of medicines called small interfering RNA (siRNA) therapies, which work at the genetic level to reduce disease symptoms.

The medication comes as a clear, colorless solution that you inject under your skin once a month. Think of it as a targeted treatment that helps your body manage the underlying genetic issue causing your porphyria attacks.

Givosiran is marketed under the brand name Givlaari and represents the first FDA-approved treatment specifically designed to prevent acute porphyria attacks rather than just treating them after they occur.

What is Givosiran Used For?

Givosiran is used to prevent acute attacks in adults with acute hepatic porphyria. This rare genetic condition affects how your body produces heme, an important component of hemoglobin that carries oxygen in your blood.

When you have acute hepatic porphyria, your body can't properly process certain chemicals called porphyrins. These build up and can cause sudden, severe attacks involving intense abdominal pain, nausea, vomiting, and sometimes neurological symptoms like muscle weakness or confusion.

The medication is specifically approved for several types of acute hepatic porphyria, including acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and ALAD-deficiency porphyria. Your doctor will confirm which type you have through specialized testing.

How Does Givosiran Work?

Givosiran works by reducing the production of a protein called ALAS1 in your liver. This protein is overactive in people with acute hepatic porphyria and contributes to the buildup of toxic substances that cause attacks.

The medication uses RNA interference technology to essentially "turn down" the production of this problematic protein. By doing so, it reduces the accumulation of toxic porphyrin precursors that trigger your symptoms.

This is considered a moderately strong medication that addresses the underlying cause of your condition rather than just masking symptoms. Clinical studies have shown it can reduce attack rates by about 70% in many patients, making it a powerful tool in managing this challenging condition.

How Should I Take Givosiran?

Givosiran is given as a subcutaneous injection, which means it's injected under the skin, typically in your stomach area, thigh, or upper arm. Your healthcare provider will teach you how to inject it yourself, or a family member can learn to help you.

The medication is given once monthly, and the dose is calculated based on your body weight. Most people receive about 2.5 mg per kilogram of body weight each month. Your doctor will determine your exact dose and show you how to measure it properly.

You don't need to take givosiran with food, and there are no specific dietary restrictions. However, it's important to store the medication in your refrigerator and let it come to room temperature before injecting. Never shake the vial, as this can damage the medication.

Choose a different injection site each month to avoid irritation. Clean the area with alcohol before injecting, and dispose of needles safely in a sharps container.

How Long Should I Take Givosiran For?

Givosiran is typically a long-term treatment that you'll continue as long as it's helping prevent your porphyria attacks. Most people with acute hepatic porphyria need ongoing treatment to maintain the benefits.

Your doctor will monitor your response to the medication over the first few months to see how well it's working. Some people notice a reduction in attacks within the first few months, while others may take longer to see the full benefits.

The decision to continue or stop treatment depends on how well the medication controls your symptoms, how you tolerate any side effects, and your overall health status. Never stop taking givosiran without discussing it with your healthcare provider first, as this could lead to a return of frequent attacks.

What Are the Side Effects of Givosiran?

Like all medications, givosiran can cause side effects, though not everyone experiences them. Understanding what to watch for can help you feel more confident about your treatment.

The most common side effects are generally mild and manageable. These include nausea, which affects about 27% of people taking the medication, and injection site reactions like redness, swelling, or itching where you inject the medicine.

Here are the most frequently reported side effects:

• Nausea (usually mild and temporary)
• Injection site reactions (redness, swelling, bruising)
• Rash or skin irritation
• Fatigue or feeling tired
• Changes in kidney function tests

These common side effects often improve as your body adjusts to the medication over the first few months of treatment.

More serious but less common side effects can occur, and it's important to be aware of them. Some people may experience kidney problems, which is why your doctor will monitor your kidney function with regular blood tests.

Rare but serious side effects include:

• Severe kidney problems (monitoring through blood tests helps catch this early)
• Severe allergic reactions (very rare but requires immediate medical attention)
• Significant changes in liver function
• Injection site infections (proper injection technique helps prevent this)

If you experience severe nausea, vomiting, unusual fatigue, or any signs of an allergic reaction like difficulty breathing or swelling of your face or throat, contact your healthcare provider immediately.

Who Should Not Take Givosiran?

Givosiran isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you. The medication is only approved for adults, so it's not recommended for children or teenagers under 18.

You should not take givosiran if you have a known allergy to the medication or any of its components. Your doctor will review the ingredient list with you if you have a history of drug allergies.

People with severe kidney disease may need special monitoring or dose adjustments, as the medication can affect kidney function. Your doctor will check your kidney function before starting treatment and regularly throughout your therapy.

Pregnant and breastfeeding women should discuss the risks and benefits carefully with their healthcare provider. While there's limited data on givosiran use during pregnancy, the medication may be considered if the benefits outweigh the potential risks.

Givosiran Brand Name

Givosiran is sold under the brand name Givlaari, manufactured by Alnylam Pharmaceuticals. This is currently the only brand name under which givosiran is available.

Givlaari comes in single-use vials containing 189 mg of givosiran in 1 mL of solution. The medication requires a prescription and is typically obtained through specialty pharmacies that have experience handling temperature-sensitive medications.

Because givosiran is a newer medication, generic versions are not yet available. The brand name Givlaari will be your only option for obtaining this treatment.

Givosiran Alternatives

Before givosiran became available, treatment options for preventing acute porphyria attacks were limited. The main alternative approach involves managing triggers and treating attacks when they occur.

Traditional management includes avoiding known triggers like certain medications, stress, fasting, and alcohol. Some people also use hemin (sold as Panhematin) to treat acute attacks, though this is given intravenously in a hospital setting.

Lifestyle modifications remain important even with givosiran treatment. These include maintaining regular eating patterns, managing stress, staying hydrated, and avoiding known trigger medications.

Some people may also benefit from pain management strategies, nutritional support, and counseling to cope with the chronic nature of porphyria. Your healthcare team can help you develop a comprehensive management plan.

Is Givosiran Better Than Hemin?

Givosiran and hemin serve different purposes in porphyria treatment, so comparing them directly isn't straightforward. Givosiran is designed to prevent attacks before they happen, while hemin is used to treat attacks that are already occurring.

Hemin (Panhematin) requires hospitalization and intravenous administration, making it impractical for regular preventive use. It's typically reserved for treating severe acute attacks that don't respond to other measures.

Givosiran offers the advantage of being a preventive treatment you can self-administer at home once monthly. Clinical studies show it can reduce attack frequency by about 70%, potentially eliminating the need for frequent hemin treatments.

Many people find that givosiran significantly improves their quality of life by reducing both the frequency and severity of attacks. However, some patients may still occasionally need hemin for breakthrough attacks, so the treatments can complement each other.